News
Mutations aid resistance, growth of malaria parasite
Some mutations that enable drug resistance in the malaria parasite Plasmodium falciparum may also help it grow, according to a study published in...
News
How EBV drives lymphomagenesis
Image by Ed Uthman Results of research published in eLIFE appear to explain how Epstein-Barr virus (EBV) controls a pair of genes to drive...
News
CHMP recommends drug for hemophilia A
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorization for lonoctocog alfa...
News
Drug dubbed ‘breakthrough’ for CTCL subtypes
Photo from Business Wire The US Food and Drug Administration (FDA) has granted breakthrough therapy designation to brentuximab vedotin (Adcetris...
News
CHMP recommends expanding use of drug in CLL
Photo courtesy of GSK The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended expanding the...
News
NCCN issues challenge to ‘bag’ vincristine
PHILADELPHIA—To ensure proper administration of vincristine, the National Comprehensive Cancer Network (NCCN) has issued a challenge to hospitals...
News
Health Canada approves drug for patients with VTE, NVAF
Image by Andre E.X.
News
Blood test can predict outcomes in DLBCL, team says
Photo by Juan D.
News
Treating RBCs with NO may make them safer
Sheep Experiment Station Research conducted in sheep indicates that pretreating red blood cells (RBCs) with nitric oxide (NO) may make it safer...
News
Tool provides info for cancer patients, survivors
receiving treatment Photo by Rhoda Baer The American Cancer Society and National Cancer Institute have launched an online tool for cancer...
News
Generic bivalirudin available in US
Photo from Business Wire Fresenius Kabi’s Bivalirudin for Injection, a generic alternative to The Medicines Company’s Angiomax, is now available...
News
Panobinostat might treat high-risk ALL subtype
Photo courtesy of Novartis Researchers say they have identified a high-risk subtype of acute lymphoblastic leukemia (ALL) that may respond to...
News
Phase 2 trial of MM drug placed on clinical hold
A phase 2 study of the antibody BI-505 in patients with multiple myeloma (MM) has been placed on full clinical hold. BioInvent International, the...
News
Link between hemolysis and infection explained
plate showing a positive streptococcus infection Photo by Bill Branson Patients who suffer from hemolysis have an increased risk of developing...
News
Antiviral appears active against tough-to-treat CMV
NEW ORLEANS—The antiviral agent maribavir has shown activity against cytomegalovirus (CMV) in a phase 2 trial. The trial included transplant...